These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3179407)

  • 1. The Corynebacterium granulosum-derived P40 immunomodulator exerts a synergistic effect on the activity of antiviral drugs in the treatment of experimental viral infections.
    Fattal-German M; Bizzini B
    Biomed Pharmacother; 1988; 42(3):217-20. PubMed ID: 3179407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the anti-viral effect of a short-term oral treatment of mice with live Saccharomyces cerevisiae cells.
    Fattal-German M; Bizzini B
    Dev Biol Stand; 1992; 77():115-20. PubMed ID: 1426651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-infectious effect of C granulosum-derived P40 immunomodulator given by aerosolization and intranasal instillation.
    Bizzini B; Carlotti M; Fattal German M
    Biomed Pharmacother; 1992; 46(10):491-4. PubMed ID: 1306363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiating the effectiveness of influenza vaccination by a combined immunostimulation with P40 immunomodulator: an experimental study in mice.
    Fattal-German M; German A; Bizzini B
    Biomed Pharmacother; 1988; 42(1):73-8. PubMed ID: 3408809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral agents.
    Hermans PE; Cockerill FR
    Mayo Clin Proc; 1983 Apr; 58(4):217-22. PubMed ID: 6339831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide.
    Masihi KN; Rohde-Schulz B; Masek K; Palache B
    Adv Exp Med Biol; 1992; 319():275-86. PubMed ID: 1414598
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical results with the Corynebacterium granulosum-derived immunomodulator P40.
    Bizzini B; Henocq E; Reynier J; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Jun; 2(1):144-53. PubMed ID: 6529476
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The restoration of impaired macrophage functions using as immunomodulator the Corynebacterium granulosum-derived P40 fraction.
    Mastroeni P; Bizzini B; Bonina L; Iannello D; Merendino RA; Delfino D; Berlinghieri MC; Leonardi MS; Arena A; Liberto MC
    Immunopharmacology; 1985 Aug; 10(1):27-34. PubMed ID: 2997082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tilorone hydrochloride: an orally active antiviral agent.
    Krueger RE; Mayer GD
    Science; 1970 Sep; 169(3951):1213-4. PubMed ID: 4317923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in antiviral therapy.
    Deeter RG; Khanderia U
    Clin Pharm; 1986 Dec; 5(12):961-76. PubMed ID: 3542344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiotropic medicinal therapy of viral infections].
    Galegov GA; Andronova VL; Leont'eva NA; L'vov ND; Petrova IG
    Vopr Virusol; 2004; 49(3):35-40. PubMed ID: 15188653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of various cytokines in mice and activation of the complement system in rats as a part of the mechanism of action of the Corynebacterium granulosum-derived P40 immunomodulator.
    Bizzini B; Carlotti M; Fattal-German M
    FEMS Microbiol Immunol; 1992 Oct; 5(4):171-80. PubMed ID: 1384603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy: antiviral agents (first of two parts).
    Hirsch MS; Swartz MN
    N Engl J Med; 1980 Apr; 302(16):903-7. PubMed ID: 6987519
    [No Abstract]   [Full Text] [Related]  

  • 18. Combinations of antiviral agents for treatment of influenza virus infections.
    Hayden FG
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():177-83. PubMed ID: 3793658
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of FCE 20696, a new synthetic immunomodulator, in models of viral and bacterial pathology.
    Verini MA; Ungheri D
    Immunopharmacology; 1989; 17(3):157-65. PubMed ID: 2475454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.